Better outcomes from one of the deadliest forms of childhood cancer might be achieved through sequencing the entire DNA of patients, according to an international study led by The Institute of Cancer ...

PURPOSE: Although positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose (18 F-FDG) has a major impact on the treatment of adult cancer, the reported experience with extracranial ...

Doctors can now choose the best treatment option for neuroblastoma, one of the common types of childhood cancer, with the help of whole-genome scan, according to researchers. The researchers called ...

Hearing that your child has neuroblastoma can be frightening and overwhelming. It can be daunting to think about the treatments your child may need and how the experience will affect your child, your ...

Neuroblastoma is the second most common type of childhood tumor. It is not known whether screening for neuroblastoma at one year of age reduces the incidence of metastatic disease or mortality due to ...

A predictive profile of genetic predisposition to neuroblastoma is emerging via genome-wide association and whole-genome sequencing analyses. However, in contrast to adult cancers, there is a general ...

Image: Neuroblastoma rosettes. Image credit: Dr. Maria Tsokos, National Cancer Institute [Public domain]. Advanced MRI techniques could test the effectiveness of drugs for children with neuroblastoma ...

Neuroblastoma is the most common extracranial tumour of childhood. This tumour originates from precursor cells of the peripheral (sympathetic) nervous system and usually arises in a paraspinal ...

This trial is no longer recruiting patients. We hope to add results when they are available. This study is looking at combining mIBG, nivolumab and dinutuximab beta to treat neuroblastoma that has ...

THE family of Robyn Smyth are nervously awaiting an MRI scan, which will show whether the teenager is still cancer free. Neuroblastoma sufferer Robyn, 14, is now halfway through a potentially ...

No Disadvantage in Outcome of Using Matched Unrelated Donors as Compared With Matched Sibling Donors for Bone Marrow Transplantation in Children With Acute Lymphoblastic Leukemia in Second Remission ...